Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. (THRX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · THRX · as of Mar 31, 2024
Ownership Breakdown
1
Institutional Holders
▼ 71 vs Q4
$1,081
Total Inst. Value
▼ $145.75M vs Q4
44.65M
Shares Outstanding
freeFloat 31.95%
267
13F Shares Held
▼ 35.99M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
THRX largest shareholders · institutional ownership
Q1 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
EVERSOURCE WEALTH ADVISORS, LLC pharmaceutical preparations | 267 | 0.06% | 0.06% | $1.08M | May 13, 2024 | — held |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 15, 2024 | EXIT |
BARCLAYS PLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Mar 24, 2026 | EXIT |
NORTHERN TRUST CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 14, 2024 | EXIT |
STATE STREET CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 15, 2024 | EXIT |
VANGUARD GROUP INC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 10, 2024 | EXIT |
WELLS FARGO & COMPANY/MN pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 10, 2024 | EXIT |
FMR LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 13, 2024 | EXIT |
DIMENSIONAL FUND ADVISORS LP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 10, 2024 | EXIT |
JPMORGAN CHASE & CO pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Dec 26, 2024 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2024 vs prior quarter
Q1 2024
0
Increased
+0 shares0
New Positions
first time holders0
Decreased
−0 shares49
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
-49
0 new / 49 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
THRX insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
15
Sell transactions
0.00
Buy/Sell ratio
$3M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Yi Kathy director | Feb 14, 2024 | D-Return | 3,250 | — | — | 0 | Form 4 ↗ |
Yi Kathy director | Feb 14, 2024 | D-Return | 99,634 | $4.03 | $402.0K | 0 | Form 4 ↗ |
Stein Steven H director | Feb 14, 2024 | D-Return | 3,250 | — | — | 0 | Form 4 ↗ |
ORBIMED ADVISORS LLC
| Feb 14, 2024 | U-Tender | 650,600 | $4.05 | $2.63M | 0 | Form 4 ↗ |
HAYDEN DONALD J JR director | Feb 14, 2024 | U-Tender | 10,000 | $4.05 | $40.5K | 0 | Form 4 ↗ |
HAYDEN DONALD J JR director | Feb 14, 2024 | D-Return | 3,250 | — | — | 0 | Form 4 ↗ |
GORDON CARL L
| Feb 14, 2024 | U-Tender | 650,600 | $4.05 | $2.63M | 0 | Form 4 ↗ |
GORDON CARL L
| Feb 14, 2024 | D-Return | 3,250 | — | — | 0 | Form 4 ↗ |
Dukes Iain D. director | Feb 14, 2024 | U-Tender | 388,324 | $4.05 | $1.57M | 0 | Form 4 ↗ |
Dukes Iain D. director | Feb 14, 2024 | D-Return | 61,549 | $4.03 | $248.3K | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Theseus Pharmaceuticals, Inc. (THRX) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 68.05%, while retail and public investors account for the remaining 31.95%.
The largest institutional shareholder of Theseus Pharmaceuticals, Inc. is EVERSOURCE WEALTH ADVISORS, LLC, holding approximately 267 shares — equal to 0.06% of outstanding shares — as of March 31, 2024.
A total of 1 institutional investors currently hold THRX stock, with a combined institutional value of approximately $1,081 as of the most recent 13F filing period.
Frequently asked questions
THRX ownershipTheseus Pharmaceuticals, Inc. (THRX) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is EVERSOURCE WEALTH ADVISORS, LLC with a 0.06% stake. Company insiders hold 68.05%. Data sourced from SEC Form 13F as of March 31, 2024.